Antagonism of sphingosine 1-phosphate receptor 2 causes a selective reduction of portal vein pressure in bile duct-ligated rodents.
about
Sphingosine-1-Phosphate Receptor-2 Antagonists: Therapeutic Potential and Potential RisksSexual dimorphism in autoimmunityConjugated bile acid-activated S1P receptor 2 is a key regulator of sphingosine kinase 2 and hepatic gene expressionEnhanced sphingosine-1-phosphate receptor 2 expression underlies female CNS autoimmunity susceptibility.Conjugated bile acids promote cholangiocarcinoma cell invasive growth through activation of sphingosine 1-phosphate receptor 2.Increased serum mitochondrial creatine kinase activity as a risk for hepatocarcinogenesis in chronic hepatitis C patients.Increased mRNA Levels of Sphingosine Kinases and S1P Lyase and Reduced Levels of S1P Were Observed in Hepatocellular Carcinoma in Association with Poorer Differentiation and Earlier Recurrence.The effect of sphingosine-1-phosphate on colonic smooth muscle contractility: Modulation by TNBS-induced colitisExosome Adherence and Internalization by Hepatic Stellate Cells Triggers Sphingosine 1-Phosphate-dependent Migration.Sphingosine kinase-1, S1P transporter spinster homolog 2 and S1P2 mRNA expressions are increased in liver with advanced fibrosis in human.HDL activation of endothelial sphingosine-1-phosphate receptor-1 (S1P1) promotes regeneration and suppresses fibrosis in the liver.Dihydroartemisinin restricts hepatic stellate cell contraction via an FXR-S1PR2-dependent mechanism.S1P Signaling and De Novo Biosynthesis in Blood Pressure HomeostasisEffects of bile acids on neurological function and disease.Sphingosine 1-Phosphate Signaling as a Target in Hepatic Fibrosis Therapy.A Novel Perspective on the ApoM-S1P Axis, Highlighting the Metabolism of ApoM and Its Role in Liver Fibrosis and Neuroinflammation.The role of sphingosine 1-phosphate receptor 2 in bile-acid-induced cholangiocyte proliferation and cholestasis-induced liver injury in mice.Dihydroartemisinin counteracts fibrotic portal hypertension via farnesoid X receptor-dependent inhibition of hepatic stellate cell contraction.
P2860
Q26738344-F9B4A3C4-27D7-489D-8153-47B56572FA3AQ28080459-F1394071-0438-4593-B949-503F87F13D1EQ28250778-C1204F32-535B-4C3A-BB75-1E95226A12BEQ33872502-84827446-D35F-4398-87AB-09FCCC3A3A18Q34079007-FE2A2C6B-71CB-4BF0-9490-FF9999915BDBQ34397639-397E6621-8F10-4F82-9677-0717A271E548Q35926140-81B05811-42DC-46DA-ADBD-0FE4B157975EQ36368910-8E677C63-A4FC-4B34-9FBE-79A3783E6D1AQ36407214-5A9B06B9-1BC8-4D42-8594-6DA0F2E91A76Q37208958-837899A6-ED35-40C7-AEA6-953A9A6B03ABQ37509813-6D29C26C-1E2C-40D0-A9F2-496F454E92B3Q38782445-960DFCD5-1772-4923-B7B5-9892C6FCFF34Q38869085-3D33B960-CDAB-44FE-8169-9AC3F66D5BE0Q38911505-D20FD671-0FCE-4C70-94F6-B7E0A86D49A6Q41547434-5D030728-DFAD-4B74-AA3F-8014A42BD944Q41573128-0290D42F-EDA5-4114-8335-6560F3DDDF8EQ45051424-F10EA565-AA91-4AED-99D1-C136DFB334E9Q48921020-BF66C4B2-F9BB-4D3D-BC5D-344D851E16A0
P2860
Antagonism of sphingosine 1-phosphate receptor 2 causes a selective reduction of portal vein pressure in bile duct-ligated rodents.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Antagonism of sphingosine 1-ph ...... in bile duct-ligated rodents.
@en
Antagonism of sphingosine 1-ph ...... in bile duct-ligated rodents.
@nl
type
label
Antagonism of sphingosine 1-ph ...... in bile duct-ligated rodents.
@en
Antagonism of sphingosine 1-ph ...... in bile duct-ligated rodents.
@nl
prefLabel
Antagonism of sphingosine 1-ph ...... in bile duct-ligated rodents.
@en
Antagonism of sphingosine 1-ph ...... in bile duct-ligated rodents.
@nl
P2093
P2860
P50
P356
P1433
P1476
Antagonism of sphingosine 1-ph ...... e in bile duct-ligated rodents
@en
P2093
Hiromitsu Yokota
Hitoshi Ikeda
Koji Shinozaki
Masakazu Nagamine
Mitsuru Yashiro
Naoko Watanabe
Natsuko Ohtomo
Takako Nishikawa
Takatoshi Koyama
Tatsuo Shimosawa
P2860
P304
P356
10.1002/HEP.25780
P407
P577
2012-10-01T00:00:00Z